{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:09:45Z","timestamp":1780452585131,"version":"3.54.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["11140666"],"award-info":[{"award-number":["11140666"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["1191874"],"award-info":[{"award-number":["1191874"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["1171570"],"award-info":[{"award-number":["1171570"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The upper respiratory tract is an obliged pathway for respiratory pathogens and a healthy microbiota may support the host's mucosal immunity preventing infection. We analyzed the nasopharyngeal microbiome in tuberculosis household contacts (HHCs) and its association with latent tuberculosis infection (TBI). A prospective cohort of HHCs was established and latent TBI status was assessed by serial interferon-\u03b3 release assay (IGRA). Nasopharyngeal swabs collected at baseline were processed for 16S rRNA gene sequencing. The 82 participants included in the analysis were classified as: (a) non-TBI [IGRA negative at baseline and follow-up, no active TB (n\u2009=\u200931)], (b) pre-TBI [IGRA negative at baseline but converted to IGRA positive or developed active TB at follow-up (n\u2009=\u200916)], and (c) TBI [IGRA positive at enrollment (n\u2009=\u200935)]. Predominant phyla were <jats:italic>Actinobacteriota<\/jats:italic>, <jats:italic>Proteobacteria<\/jats:italic>, <jats:italic>Firmicutes<\/jats:italic> and <jats:italic>Bacteroidota<\/jats:italic>. TBI group had a lower alpha diversity compared to non-TBI (p<jats:sub>adj<\/jats:sub>\u2009=\u20090.04) and pre-TBI (p<jats:sub>adj<\/jats:sub>\u2009=\u20090.04). Only TBI and non-TBI had beta diversity differences (p<jats:sub>adj<\/jats:sub>\u2009=\u20090.035). Core microbiomes\u2019 had unique genera, and genus showed differential abundance among groups. HHCs with established latent TBI showed reduced nasopharyngeal microbial diversity with distinctive taxonomical composition. Whether a pre-existing microbiome feature favors, are a consequence, or protects against <jats:italic>Mycobacterium tuberculosis<\/jats:italic> needs further investigation.<\/jats:p>","DOI":"10.1038\/s41598-023-34052-8","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:02:59Z","timestamp":1683280979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reduced microbial diversity of the nasopharyngeal microbiome in household contacts with latent tuberculosis infection"],"prefix":"10.1038","volume":"13","author":[{"given":"Cinthya","family":"Ruiz-Tagle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Ugalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Naves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Araos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elvira","family":"Balcells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"34052_CR1","unstructured":"Global tuberculosis report 2020. (Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO)."},{"key":"34052_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.01578-2017","volume":"51","author":"C Acu\u00f1a-Villaorduna","year":"2018","unstructured":"Acu\u00f1a-Villaorduna, C. et al. Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease. Eur. Respir. J. 51, 1. https:\/\/doi.org\/10.1183\/13993003.01578-2017 (2018).","journal-title":"Eur. Respir. J."},{"key":"34052_CR3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/cid\/ciz1044","volume":"71","author":"MR Reichler","year":"2020","unstructured":"Reichler, M. R. et al. Duration of exposure among close contacts of patients with infectious tuberculosis and risk of latent tuberculosis infection. Clin. Infect. Dis. 71, 1627\u20131634. https:\/\/doi.org\/10.1093\/cid\/ciz1044 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"34052_CR4","doi-asserted-by":"publisher","first-page":"828939","DOI":"10.1155\/2013\/828939","volume":"2013","author":"P Narasimhan","year":"2013","unstructured":"Narasimhan, P., Wood, J., Macintyre, C. R. & Mathai, D. Risk factors for tuberculosis. Pulm Med 2013, 828939. https:\/\/doi.org\/10.1155\/2013\/828939 (2013).","journal-title":"Pulm Med"},{"key":"34052_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tube.2015.04.003","volume":"95","author":"P Salgame","year":"2015","unstructured":"Salgame, P., Geadas, C., Collins, L., Jones-Lopez, E. & Ellner, J. J. Latent tuberculosis infection\u2013Revisiting and revising concepts. Tuberculosis (Edinb.) 95, 373\u2013384. https:\/\/doi.org\/10.1016\/j.tube.2015.04.003 (2015).","journal-title":"Tuberculosis (Edinb.)"},{"key":"34052_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/IAI.02627-14","volume":"83","author":"A Casadevall","year":"2015","unstructured":"Casadevall, A. & Pirofski, L. A. What is a host? Incorporating the microbiota into the damage-response framework. Infect. Immun. 83, 2\u20137. https:\/\/doi.org\/10.1128\/IAI.02627-14 (2015).","journal-title":"Infect. Immun."},{"key":"34052_CR7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/bmj.j831","volume":"356","author":"VB Young","year":"2017","unstructured":"Young, V. B. The role of the microbiome in human health and disease: An introduction for clinicians. BMJ 356, 831. https:\/\/doi.org\/10.1136\/bmj.j831 (2017).","journal-title":"BMJ"},{"key":"34052_CR8","doi-asserted-by":"publisher","first-page":"26263","DOI":"10.3390\/ijms161125957","volume":"16","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y., Lun, C. Y. & Tsui, S. K. Metagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host Microbiome. Int. J. Mol. Sci. 16, 26263\u201326279. https:\/\/doi.org\/10.3390\/ijms161125957 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"34052_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1021\/acsinfecdis.7b00232","volume":"4","author":"AJ Waldman","year":"2018","unstructured":"Waldman, A. J. & Balskus, E. P. The human microbiota, infectious disease, and global health: Challenges and opportunities. ACS Infect. Dis. 4, 14\u201326. https:\/\/doi.org\/10.1021\/acsinfecdis.7b00232 (2018).","journal-title":"ACS Infect. Dis."},{"key":"34052_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","volume":"15","author":"WH Man","year":"2017","unstructured":"Man, W. H., de SteenhuijsenPiters, W. A. & Bogaert, D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat. Rev. Microbiol. 15, 259\u2013270. https:\/\/doi.org\/10.1038\/nrmicro.2017.14 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"34052_CR11","doi-asserted-by":"publisher","first-page":"637430","DOI":"10.3389\/fmicb.2021.637430","volume":"12","author":"MP Ventero","year":"2021","unstructured":"Ventero, M. P. et al. Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19. Front. Microbiol. 12, 637430. https:\/\/doi.org\/10.3389\/fmicb.2021.637430 (2021).","journal-title":"Front. Microbiol."},{"key":"34052_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3345\/cep.2020.01452","volume":"64","author":"HM Kang","year":"2021","unstructured":"Kang, H. M. & Kang, J. H. Effects of nasopharyngeal microbiota in respiratory infections and allergies. Clin. Exp. Pediatr. 64, 543\u2013551. https:\/\/doi.org\/10.3345\/cep.2020.01452 (2021).","journal-title":"Clin. Exp. Pediatr."},{"key":"34052_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41426-018-0097-y","volume":"7","author":"W Dai","year":"2018","unstructured":"Dai, W. et al. The concordance between upper and lower respiratory microbiota in children with Mycoplasma pneumoniae pneumonia. Emerg. Microbes Infect. 7, 92. https:\/\/doi.org\/10.1038\/s41426-018-0097-y (2018).","journal-title":"Emerg. Microbes Infect."},{"key":"34052_CR14","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1128\/JCM.03280-13","volume":"52","author":"O Sakwinska","year":"2014","unstructured":"Sakwinska, O. et al. Nasopharyngeal microbiota in healthy children and pneumonia patients. J. Clin. Microbiol. 52, 1590\u20131594. https:\/\/doi.org\/10.1128\/JCM.03280-13 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"34052_CR15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/cid\/ciab568","volume":"74","author":"BW Haak","year":"2022","unstructured":"Haak, B. W. et al. Bacterial and viral respiratory tract microbiota and host characteristics in adults with lower respiratory tract infections: A case-control study. Clin. Infect. Dis. 74, 776\u2013784. https:\/\/doi.org\/10.1093\/cid\/ciab568 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"34052_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/2049-2618-2-44","volume":"2","author":"AJ Cremers","year":"2014","unstructured":"Cremers, A. J. et al. The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition. Microbiome 2, 44. https:\/\/doi.org\/10.1186\/2049-2618-2-44 (2014).","journal-title":"Microbiome"},{"key":"34052_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2049-2618-2-29","volume":"2","author":"LE Botero","year":"2014","unstructured":"Botero, L. E. et al. Respiratory tract clinical sample selection for microbiota analysis in patients with pulmonary tuberculosis. Microbiome 2, 29. https:\/\/doi.org\/10.1186\/2049-2618-2-29 (2014).","journal-title":"Microbiome"},{"key":"34052_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12887-019-1782-2","volume":"19","author":"W Li","year":"2019","unstructured":"Li, W., Zhu, Y., Liao, Q., Wang, Z. & Wan, C. Characterization of gut microbiota in children with pulmonary tuberculosis. BMC Pediatr. 19, 445. https:\/\/doi.org\/10.1186\/s12887-019-1782-2 (2019).","journal-title":"BMC Pediatr."},{"key":"34052_CR19","first-page":"404","volume":"64","author":"DK Warndorff","year":"1996","unstructured":"Warndorff, D. K. et al. Polymerase chain reaction of nasal swabs from tuberculosis patients and their contacts. Int. J. Leprosy 64, 404\u2013408 (1996).","journal-title":"Int. J. Leprosy"},{"key":"34052_CR20","doi-asserted-by":"publisher","first-page":"848","DOI":"10.5588\/ijtld.15.0872","volume":"20","author":"ME Balcells","year":"2016","unstructured":"Balcells, M. E. et al. M. tuberculosis DNA detection in nasopharyngeal mucosa can precede tuberculosis development in contacts. Int. J. Tuberc. Lung Dis. 20, 848\u2013852. https:\/\/doi.org\/10.5588\/ijtld.15.0872 (2016).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"34052_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","volume":"15","author":"KF Budden","year":"2017","unstructured":"Budden, K. F. et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat. Rev. Microbiol. 15, 55\u201363. https:\/\/doi.org\/10.1038\/nrmicro.2016.142 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"34052_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fimmu.2016.00529","volume":"7","author":"N Khan","year":"2016","unstructured":"Khan, N. et al. Alteration in the Gut Microbiota Provokes Susceptibility to Tuberculosis. Front. Immunol. 7, 529. https:\/\/doi.org\/10.3389\/fimmu.2016.00529 (2016).","journal-title":"Front. Immunol."},{"key":"34052_CR23","doi-asserted-by":"publisher","unstructured":"Perry, S. et al. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One 5, e8804. https:\/\/doi.org\/10.1371\/journal.pone.0008804 (2010).","DOI":"10.1371\/journal.pone.0008804"},{"key":"34052_CR24","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1038\/ncomms3106","volume":"4","author":"J Wang","year":"2013","unstructured":"Wang, J. et al. Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages. Nat. Commun. 4, 2106. https:\/\/doi.org\/10.1038\/ncomms3106 (2013).","journal-title":"Nat. Commun."},{"key":"34052_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.antiviral.2016.06.002","volume":"132","author":"TA Rice","year":"2016","unstructured":"Rice, T. A. et al. Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infection. Antiviral Res. 132, 131\u2013140. https:\/\/doi.org\/10.1016\/j.antiviral.2016.06.002 (2016).","journal-title":"Antiviral Res."},{"key":"34052_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/22221751.2020.1737578","volume":"9","author":"T Qin","year":"2020","unstructured":"Qin, T. et al. Super-dominant pathobiontic bacteria in the nasopharyngeal microbiota as causative agents of secondary bacterial infection in influenza patients. Emerg. Microbes Infect. 9, 605\u2013615. https:\/\/doi.org\/10.1080\/22221751.2020.1737578 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"34052_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/1471-2164-14-390","volume":"14","author":"Z Ling","year":"2013","unstructured":"Ling, Z. et al. Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates. BMC Genom. 14, 390. https:\/\/doi.org\/10.1186\/1471-2164-14-390 (2013).","journal-title":"BMC Genom."},{"key":"34052_CR28","doi-asserted-by":"publisher","first-page":"625581","DOI":"10.3389\/fcimb.2021.625581","volume":"11","author":"C Nardelli","year":"2021","unstructured":"Nardelli, C. et al. Nasopharyngeal microbiome signature in COVID-19 positive patients: Can we definitively get a role to fusobacterium periodonticum?. Front Cell Infect Microbiol 11, 625581. https:\/\/doi.org\/10.3389\/fcimb.2021.625581 (2021).","journal-title":"Front Cell Infect Microbiol"},{"key":"34052_CR29","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s10096-018-3305-8","volume":"37","author":"S Edouard","year":"2018","unstructured":"Edouard, S. et al. The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens. Eur J Clin Microbiol Infect Dis 37, 1725\u20131733. https:\/\/doi.org\/10.1007\/s10096-018-3305-8 (2018).","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"34052_CR30","doi-asserted-by":"publisher","first-page":"15715","DOI":"10.1038\/s41598-021-95197-y","volume":"11","author":"EC Rouchka","year":"2021","unstructured":"Rouchka, E. C. et al. Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients. Sci. Rep. 11, 15715. https:\/\/doi.org\/10.1038\/s41598-021-95197-y (2021).","journal-title":"Sci. Rep."},{"key":"34052_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/2049-2618-2-22","volume":"2","author":"EK Allen","year":"2014","unstructured":"Allen, E. K. et al. Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge. Microbiome 2, 22. https:\/\/doi.org\/10.1186\/2049-2618-2-22 (2014).","journal-title":"Microbiome"},{"key":"34052_CR32","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.3389\/fmicb.2017.02372","volume":"8","author":"I De Boeck","year":"2017","unstructured":"De Boeck, I. et al. Comparing the healthy nose and nasopharynx microbiota reveals continuity as well as niche-specificity. Front. Microbiol. 8, 2372. https:\/\/doi.org\/10.3389\/fmicb.2017.02372 (2017).","journal-title":"Front. Microbiol."},{"key":"34052_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2022.102231","author":"Y Huang","year":"2022","unstructured":"Huang, Y. et al. Alterations in the nasopharyngeal microbiota associated with active and latent tuberculosis. Tuberculosis https:\/\/doi.org\/10.1016\/j.tube.2022.102231 (2022).","journal-title":"Tuberculosis"},{"key":"34052_CR34","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00018-019-03370-4","volume":"77","author":"OA Eribo","year":"2020","unstructured":"Eribo, O. A. et al. The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?. Cell Mol. Life Sci. 77, 1497\u20131509. https:\/\/doi.org\/10.1007\/s00018-019-03370-4 (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"34052_CR35","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/s2213-2600(18)30501-0","volume":"7","author":"CC Naidoo","year":"2019","unstructured":"Naidoo, C. C. et al. The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda. Lancet Respir. Med. 7, 892\u2013906. https:\/\/doi.org\/10.1016\/s2213-2600(18)30501-0 (2019).","journal-title":"Lancet Respir. Med."},{"key":"34052_CR36","doi-asserted-by":"publisher","unstructured":"Cheung, M. K. et al. Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing. PLoS One 8, e54574, doi:https:\/\/doi.org\/10.1371\/journal.pone.0054574 (2013).","DOI":"10.1371\/journal.pone.0054574"},{"key":"34052_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1471-2180-12-276","volume":"12","author":"Z Cui","year":"2012","unstructured":"Cui, Z. et al. Complex sputum microbial composition in patients with pulmonary tuberculosis. BMC Microbiol. 12, 276. https:\/\/doi.org\/10.1186\/1471-2180-12-276 (2012).","journal-title":"BMC Microbiol."},{"key":"34052_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.tube.2018.02.006","volume":"109","author":"BY Hong","year":"2018","unstructured":"Hong, B. Y., Paulson, J. N., Stine, O. C., Weinstock, G. M. & Cervantes, J. L. Meta-analysis of the lung microbiota in pulmonary tuberculosis. Tuberculosis (Edinb.) 109, 102\u2013108. https:\/\/doi.org\/10.1016\/j.tube.2018.02.006 (2018).","journal-title":"Tuberculosis (Edinb.)"},{"key":"34052_CR39","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1080\/22221751.2020.1783188","volume":"9","author":"Y Hu","year":"2020","unstructured":"Hu, Y. et al. Metagenomic analysis of the lung microbiome in pulmonary tuberculosis\u2014A pilot study. Emerg. Microbes Infect. 9, 1444\u20131452. https:\/\/doi.org\/10.1080\/22221751.2020.1783188 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"34052_CR40","doi-asserted-by":"publisher","unstructured":"Wu, J. et al. Sputum microbiota associated with new, recurrent and treatment failure tuberculosis. PLoS One 8, e83445, doi:https:\/\/doi.org\/10.1371\/journal.pone.0083445 (2013).","DOI":"10.1371\/journal.pone.0083445"},{"key":"34052_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mSystems.00187-18","volume":"3","author":"IF Escapa","year":"2018","unstructured":"Escapa, I. F. et al. New Insights into Human Nostril Microbiome from the Expanded Human Oral Microbiome Database (eHOMD): a Resource for the Microbiome of the Human Aerodigestive Tract. mSystems 3, 1. https:\/\/doi.org\/10.1128\/mSystems.00187-18 (2018).","journal-title":"mSystems"},{"key":"34052_CR42","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/ismej.2017.119","volume":"11","author":"BJ Callahan","year":"2017","unstructured":"Callahan, B. J., McMurdie, P. J. & Holmes, S. P. Exact sequence variants should replace operational taxonomic units in marker-gene data analysis. ISME J. 11, 2639\u20132643. https:\/\/doi.org\/10.1038\/ismej.2017.119 (2017).","journal-title":"ISME J."},{"key":"34052_CR43","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.isci.2021.102978","volume":"24","author":"I De Boeck","year":"2021","unstructured":"De Boeck, I. et al. The nasal mutualist Dolosigranulum pigrum AMBR11 supports homeostasis via multiple mechanisms. iScience 24, 1078. https:\/\/doi.org\/10.1016\/j.isci.2021.102978 (2021).","journal-title":"iScience"},{"key":"34052_CR44","doi-asserted-by":"publisher","unstructured":"Laufer, A. S. et al. Microbial communities of the upper respiratory tract and otitis media in children. mBio 2, e00245\u201300210. https:\/\/doi.org\/10.1128\/mBio.00245-10 (2011).","DOI":"10.1128\/mBio.00245-10"},{"key":"34052_CR45","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1128\/AEM.01051-12","volume":"78","author":"MM Pettigrew","year":"2012","unstructured":"Pettigrew, M. M. et al. Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children. Appl Environ Microbiol 78, 6262\u20136270. https:\/\/doi.org\/10.1128\/AEM.01051-12 (2012).","journal-title":"Appl Environ Microbiol"},{"key":"34052_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mSphere.00852-20","volume":"5","author":"SD Brugger","year":"2020","unstructured":"Brugger, S. D. et al. Dolosigranulum pigrum cooperation and competition in human nasal microbiota. mSphere 5, 1. https:\/\/doi.org\/10.1128\/mSphere.00852-20 (2020).","journal-title":"mSphere"},{"key":"34052_CR47","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1128\/AAC.44.7.2001-2003.2000","volume":"44","author":"L Laclaire","year":"2000","unstructured":"Laclaire, L. & Facklam, R. Antimicrobial susceptibility and clinical sources of Dolosigranulum pigrum cultures. Antimicrob Agents Chemother 44, 2001\u20132003. https:\/\/doi.org\/10.1128\/AAC.44.7.2001-2003.2000 (2000).","journal-title":"Antimicrob Agents Chemother"},{"key":"34052_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph18042174","volume":"18","author":"M Rueca","year":"2021","unstructured":"Rueca, M. et al. Investigation of nasal\/oropharyngeal microbial community of COVID-19 patients by 16S rDNA sequencing. Int. J. Environ. Res. Public Health 18, 1. https:\/\/doi.org\/10.3390\/ijerph18042174 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"34052_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2180-9-124","volume":"9","author":"WD Jamieson","year":"2009","unstructured":"Jamieson, W. D., Pehl, M. J., Gregory, G. A. & Orwin, P. M. Coordinated surface activities in Variovorax paradoxus EPS. BMC Microbiol 9, 124. https:\/\/doi.org\/10.1186\/1471-2180-9-124 (2009).","journal-title":"BMC Microbiol"},{"key":"34052_CR50","doi-asserted-by":"publisher","unstructured":"Mindt, B. C. & DiGiandomenico, A. Microbiome Modulation as a Novel Strategy to Treat and Prevent Respiratory Infections. Antibiotics (Basel) 11, 1. https:\/\/doi.org\/10.3390\/antibiotics11040474 (2022).","DOI":"10.3390\/antibiotics11040474"},{"key":"34052_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41392-021-00614-3","volume":"6","author":"S Ma","year":"2021","unstructured":"Ma, S. et al. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19. Signal Transduct. Target Ther. 6, 191. https:\/\/doi.org\/10.1038\/s41392-021-00614-3 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"34052_CR52","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41598-020-80533-5","volume":"11","author":"N Bayal","year":"2021","unstructured":"Bayal, N. et al. Structural aspects of lesional and non-lesional skin microbiota reveal key community changes in leprosy patients from India. Sci. Rep. 11, 3294. https:\/\/doi.org\/10.1038\/s41598-020-80533-5 (2021).","journal-title":"Sci. Rep."},{"key":"34052_CR53","doi-asserted-by":"publisher","unstructured":"van Rensburg, J. J. et al. The Human Skin Microbiome Associates with the Outcome of and Is Influenced by Bacterial Infection. mBio 6, e01315\u201301315, doi:https:\/\/doi.org\/10.1128\/mBio.01315-15 (2015).","DOI":"10.1128\/mBio.01315-15"},{"key":"34052_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12915-019-0703-z","volume":"17","author":"C Kumpitsch","year":"2019","unstructured":"Kumpitsch, C., Koskinen, K., Schopf, V. & Moissl-Eichinger, C. The microbiome of the upper respiratory tract in health and disease. BMC Biol. 17, 87. https:\/\/doi.org\/10.1186\/s12915-019-0703-z (2019).","journal-title":"BMC Biol."},{"key":"34052_CR55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s42255-021-00348-0","volume":"3","author":"T Wilmanski","year":"2021","unstructured":"Wilmanski, T. et al. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat. Metab. 3, 274\u2013286. https:\/\/doi.org\/10.1038\/s42255-021-00348-0 (2021).","journal-title":"Nat. Metab."},{"key":"34052_CR56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4067\/s0034-98872020000200151","volume":"148","author":"ME Balcells","year":"2020","unstructured":"Balcells, M. E. et al. Systematic screening of adult household contacts of patients with active pulmonary tuberculosis reveals high rates of new infections during follow-up. Rev. Med. Chil. 148, 151\u2013159. https:\/\/doi.org\/10.4067\/s0034-98872020000200151 (2020).","journal-title":"Rev. Med. Chil."},{"key":"34052_CR57","doi-asserted-by":"publisher","unstructured":"Wikell, A. et al. The Impact of Borderline Quantiferon-TB Gold Plus Results for Latent Tuberculosis Screening under Routine Conditions in a Low-Endemicity Setting. J. Clin. Microbiol. 59, e0137021. https:\/\/doi.org\/10.1128\/JCM.01370-21 (2021).","DOI":"10.1128\/JCM.01370-21"},{"key":"34052_CR58","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583. https:\/\/doi.org\/10.1038\/nmeth.3869 (2016).","journal-title":"Nat. Methods"},{"key":"34052_CR59","unstructured":"R: A language and environment for statistical computing. https:\/\/www.R-project.org\/ (2021)."},{"key":"34052_CR60","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucl. Acids Res. 41, D590-596. https:\/\/doi.org\/10.1093\/nar\/gks1219 (2013).","journal-title":"Nucl. Acids Res."},{"key":"34052_CR61","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: Improvements in performance and usability. Mol. Biol. Evol. 30, 772\u2013780. https:\/\/doi.org\/10.1093\/molbev\/mst010 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"34052_CR62","doi-asserted-by":"publisher","unstructured":"Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2--approximately maximum-likelihood trees for large alignments. PLoS One 5, e9490. https:\/\/doi.org\/10.1371\/journal.pone.0009490 (2010).","DOI":"10.1371\/journal.pone.0009490"},{"key":"34052_CR63","doi-asserted-by":"publisher","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8, e61217. https:\/\/doi.org\/10.1371\/journal.pone.0061217 (2013).","DOI":"10.1371\/journal.pone.0061217"},{"key":"34052_CR64","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2. (Springer Science+Business Media, 2009).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"34052_CR65","unstructured":"Lahti, L. & Shetty, S. Tools for microbiome analysis in R. http:\/\/microbiome.github.com\/microbiome (2017)."},{"key":"34052_CR66","doi-asserted-by":"publisher","unstructured":"Patil, I. Visualizations with statistical details: The 'ggstatsplot' approach. J. Open Source Softw. 6, https:\/\/doi.org\/10.21105\/joss.03167 (2021).","DOI":"10.21105\/joss.03167"},{"key":"34052_CR67","doi-asserted-by":"publisher","unstructured":"Silverman, J. D., Washburne, A. D., Mukherjee, S. & David, L. A. A phylogenetic transform enhances analysis of compositional microbiota data. Elife 6, doi:https:\/\/doi.org\/10.7554\/eLife.21887 (2017).","DOI":"10.7554\/eLife.21887"},{"key":"34052_CR68","unstructured":"Oksanen, J. et al. (2020). vegan: Community Ecology Package. R package version 2.5\u20137. https:\/\/CRAN.R-project.org\/package=vegan."},{"key":"34052_CR69","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1038\/s41467-020-17041-7","volume":"11","author":"H Lin","year":"2020","unstructured":"Lin, H. & Peddada, S. D. Analysis of compositions of microbiomes with bias correction. Nat Commun 11, 3514. https:\/\/doi.org\/10.1038\/s41467-020-17041-7 (2020).","journal-title":"Nat Commun"},{"key":"34052_CR70","unstructured":"RStudio: Integrated Development for R. RStudio, PBC. http:\/\/www.rstudio.com\/. (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34052-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34052-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34052-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:16:45Z","timestamp":1683281805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34052-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34052"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34052-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"22 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7301"}}